Post Stroke Walking Kinematics Using the Honda Walking Assist Robotic Exoskeleton
Launched by COLLEGE OF ST. SCHOLASTICA, INC. · Jan 31, 2019
Trial Information
Current as of August 26, 2025
Completed
Keywords
ClinConnect Summary
Following stroke walking dysfunction is prevalent. Traditional rehabilitation methods fall short of achieving desirable walking outcomes for most people who experience stroke. Robotic methods to assist walking, such as the Honda Walking Assist Device (HWA) Robot from Honda R \& D Americas Inc., are being explored as a means of improving the recovery of walking post stroke. Prior to examining the effectiveness of exoskeletal robots for walking recovery it is important to understand their effect on kinematic and muscle responses during walking. Kinematic and muscle responses at the hip during...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥12 weeks but \<1 year post stroke at time of study participation
- • Age: 18-85 years
- • Ability to walk a minimum of 10 meters with standby assistance with or without orthosis or assistive device (Functional Ambulation categories 3, 4 or 5)
- • Able to follow three step commands
- • Express the ability to understand study tasks and purpose
- • Able and willing to provide written informed consent
- • Living in the community with the ability to travel to maurices Community Clinic for testing
- • Willingness to wear the StepWatch pedometer for a period of 3 days in their home
- • (If applicable) ≥ 90 days post major orthopedic surgery (such as a joint replacement)
- • (If applicable) ≥ 6 months post cardiac surgery
- Exclusion Criteria:
- • Serious cardiac conditions (hospitalized for myocardial infarction or heart surgery within 3 months, congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
- • Severe arthritis or orthopedic conditions that limit lower extremity range of motion (\> 10° or \< 90° knee flexion, lacking \> 25° hip extension, \>15° from neutral plantar flexion.)
- • Preexisting neurologic disorders such as Dementia, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Parkinson's Disease or Ataxia.
- • History of lower limb amputation, non-healing ulcers, legal blindness or severe visual impairment
About College Of St. Scholastica, Inc.
The College of St. Scholastica, Inc. is a distinguished higher education institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interprofessional education and evidence-based practice, the College fosters a collaborative environment for healthcare professionals and students to explore groundbreaking therapies and improve patient outcomes. By leveraging its extensive academic resources and commitment to community service, the College of St. Scholastica plays a pivotal role in enhancing clinical research and contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Duluth, Minnesota, United States
Patients applied
Trial Officials
Alexandra L Borstad, PhD
Principal Investigator
College of St. Scholastica
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials